BACKGROUND: Inflammation and immune response have potential prognostic implications for breast cancer survivors. We examined how postdiagnosis diet quality is cross-sectionally related to biomarkers of inflammation and adipose-derived hormones among breast cancer survivors and determined whether physical activity or body size modified any observed associations. METHODS: Participants included 746 women diagnosed with stage 0 to IIIA breast cancer. Thirty months after diagnosis, the women completed food frequency questionnaires. We scored diet quality with the Healthy Eating Index (HEI)-2005. Serum concentrations of C-reactive protein (CRP), serum amyloid A, leptin, and adiponectin were measured in fasting 30 mL blood samples. Log biomarker values were regressed on quartiles of HEI-2005 scores in multivariate models, and beta scores were exponentiated and expressed as geometric means within quartiles of HEI-2005 scores. RESULTS: Women with better versus poor quality postdiagnosis diets, as defined by higher HEI-2005 scores (Q4 versus Q1), had lower concentrations of CRP (1.6 mg/L versus 2.5 mg/L), but no significant difference in concentrations of serum amyloid A, leptin, or adiponectin. Among women not engaging in recreational physical activity after diagnosis, better diet quality was associated with lower CRP concentrations (2.5 mg/L versus 5.0 mg/L), but no association was observed among women engaging in any recreational physical activity (1.4 mg/L versus 1.6 mg/L; P heterogeneity = 0.03). CONCLUSIONS: Among breast cancer survivors, a better-quality diet seems to be associated with lower levels of chronic inflammation. IMPACT: Lower levels of chronic inflammation have been associated with improved survival after breast cancer. (c) 2010 AACR.
BACKGROUND:Inflammation and immune response have potential prognostic implications for breast cancer survivors. We examined how postdiagnosis diet quality is cross-sectionally related to biomarkers of inflammation and adipose-derived hormones among breast cancer survivors and determined whether physical activity or body size modified any observed associations. METHODS:Participants included 746 women diagnosed with stage 0 to IIIA breast cancer. Thirty months after diagnosis, the women completed food frequency questionnaires. We scored diet quality with the Healthy Eating Index (HEI)-2005. Serum concentrations of C-reactive protein (CRP), serum amyloid A, leptin, and adiponectin were measured in fasting 30 mL blood samples. Log biomarker values were regressed on quartiles of HEI-2005 scores in multivariate models, and beta scores were exponentiated and expressed as geometric means within quartiles of HEI-2005 scores. RESULTS:Women with better versus poor quality postdiagnosis diets, as defined by higher HEI-2005 scores (Q4 versus Q1), had lower concentrations of CRP (1.6 mg/L versus 2.5 mg/L), but no significant difference in concentrations of serum amyloid A, leptin, or adiponectin. Among women not engaging in recreational physical activity after diagnosis, better diet quality was associated with lower CRP concentrations (2.5 mg/L versus 5.0 mg/L), but no association was observed among women engaging in any recreational physical activity (1.4 mg/L versus 1.6 mg/L; P heterogeneity = 0.03). CONCLUSIONS: Among breast cancer survivors, a better-quality diet seems to be associated with lower levels of chronic inflammation. IMPACT: Lower levels of chronic inflammation have been associated with improved survival after breast cancer. (c) 2010 AACR.
Authors: Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor Journal: Circulation Date: 2003-01-28 Impact factor: 29.690
Authors: Melinda L Irwin; Anne McTiernan; Leslie Bernstein; Frank D Gilliland; Richard Baumgartner; Kathy Baumgartner; Rachel Ballard-Barbash Journal: Med Sci Sports Exerc Date: 2004-09 Impact factor: 5.411
Authors: Anne McTiernan; Kumar B Rajan; Shelley S Tworoger; Melinda Irwin; Leslie Bernstein; Richard Baumgartner; Frank Gilliland; Frank Z Stanczyk; Yutaka Yasui; Rachel Ballard-Barbash Journal: J Clin Oncol Date: 2003-05-15 Impact factor: 44.544
Authors: Anna M Wolf; Dominik Wolf; Holger Rumpold; Barbara Enrich; Herbert Tilg Journal: Biochem Biophys Res Commun Date: 2004-10-15 Impact factor: 3.575
Authors: Anne K Swisher; Jame Abraham; Daniel Bonner; Diana Gilleland; Gerald Hobbs; Sobha Kurian; Mary Anne Yanosik; Linda Vona-Davis Journal: Support Care Cancer Date: 2015-03-01 Impact factor: 3.603
Authors: Wen-Qing Li; Yikyung Park; Jennifer W Wu; Alisa M Goldstein; Philip R Taylor; Albert R Hollenbeck; Neal D Freedman; Christian C Abnet Journal: Am J Clin Nutr Date: 2014-01-08 Impact factor: 7.045
Authors: Lisa M Shank; Marian Tanofsky-Kraff; Nichole R Kelly; Natasha A Schvey; Shannon E Marwitz; Rim D Mehari; Sheila M Brady; Andrew P Demidowich; Miranda M Broadney; Ovidiu A Galescu; Courtney K Pickworth; Susan Z Yanovski; Jack A Yanovski Journal: Child Obes Date: 2016-10-12 Impact factor: 2.992
Authors: Stephanie M George; Melinda L Irwin; Ashley W Smith; Marian L Neuhouser; Jill Reedy; Anne McTiernan; Catherine M Alfano; Leslie Bernstein; Cornelia M Ulrich; Kathy B Baumgartner; Steven C Moore; Demetrius Albanes; Susan T Mayne; Mitchell H Gail; Rachel Ballard-Barbash Journal: Cancer Causes Control Date: 2011-02-22 Impact factor: 2.506
Authors: Shannon M Christy; Catherine E Mosher; Richard Sloane; Denise C Snyder; David F Lobach; Wendy Demark-Wahnefried Journal: J Am Diet Assoc Date: 2011-12
Authors: Wen-Qing Li; Yikyung Park; Jennifer W Wu; Jian-Song Ren; Alisa M Goldstein; Philip R Taylor; Albert R Hollenbeck; Neal D Freedman; Christian C Abnet Journal: Clin Gastroenterol Hepatol Date: 2013-04-13 Impact factor: 11.382